[Federal Register Volume 84, Number 183 (Friday, September 20, 2019)]
[Notices]
[Page 49555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20412]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Galephar 
Pharmaceutical Research Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before October 21, 2019. 
Such persons may also file a written request for a hearing on the 
application on or before October 21, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on June 10, 2019, Galephar Pharmaceutical Research Inc., 
#100 Carr 198 Industrial Park, Juncos, Puerto Rico, 00777 applied to be 
registered as an importer of the following basic class of controlled 
substance:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Hydromorphone.........................       9150  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substance in 
finished dosage form for analytical purpose only.

    Dated: August 22, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019-20412 Filed 9-19-19; 8:45 am]
 BILLING CODE 4410-09-P